← Leaderboards
David Gagnon
Mainehealth
$1,765,273
Attributed
$1,765,273
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $497.3K · FY2021–24$500K$375K$250K$125K$0
'21
'22
'23
'24
Funding mix
By agency
NIH$1,765,273 · 1
By mechanism
P20$1,765,273 · 1
Top collaborators
No co-investigators on record.
Most similar at Mainehealth
Same institution · by research overlap
- Teresa May$1,807,800
- Douglas B Sawyer$11,201,014
Others in their field
Other Emerging Leaders on “Centers Of Research Excellence”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$143,577,666
- Prasant Mohapatra · University Of California At Davis$55,327,866
- Scott Hensley · University Of Pennsylvania$44,549,615
- Stephan Bour · Digital Infuzion, Inc.$24,880,214
- S. Mark Tompkins · University Of Georgia$19,973,302
- Robert Wilson Frenck · Cincinnati Childrens Hosp Med Ctr$18,477,724
Research focus
Centers Of Research ExcellenceAffectAcute CareAnti-Bacterial AgentsAntibiotic ProphylaxisAntibiotic ResistanceAmoxicillinAdenosineAntiinflammatory EffectAntimicrobialAntimicrobial EffectBacteremiaBacterial Drug ResistanceBacterial ResistanceBactericideAntibioticsAnti-Inflammatory AgentsBlindedBrain InjuriesCardiopulmonary ResuscitationCareerCaringCeftriaxoneCephalosporins
Grant awards (4)
Ceftriaxone Immunomodulation and Antimicrobial Effects After Cardiac Arrest$369,314
P20 · FY2024 · GM · contact PI
Ceftriaxone Immunomodulation and Antimicrobial Effects After Cardiac Arrest$497,251
P20 · FY2023 · GM · contact PI
Ceftriaxone Immunomodulation and Antimicrobial Effects After Cardiac Arrest$469,755
P20 · FY2022 · GM · contact PI
Ceftriaxone Immunomodulation and Antimicrobial Effects After Cardiac Arrest$428,953
P20 · FY2021 · GM · contact PI